FDA Clearance Tracker · K180319
Bausch + Lomb Boston Advance Cleaner, Bausch + Lomb Boston Advance Conditioning Solution
Last checked: Nov 20, 2026Latest source record: Mar 27, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Mar 27, 2018
Substantially Equivalent
Time to decision
50 days
Received Feb 5, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K180319
- Device name
- Bausch + Lomb Boston Advance Cleaner, Bausch + Lomb Boston Advance Conditioning Solution
- Applicant
- Bausch and Lomb, Incorporated
- Applicant location
- Rochester, NY
- Received
- Feb 5, 2018
- Decided
- Mar 27, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 886.5918
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MRC. The earliest in FDA's data is K974466, decided Feb 19, 1998.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K180319
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bausch and Lomb, Incorporated
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252052 · Decided Mar 25, 2026 · 267 days after receipt
Device type: Unit, Phacofragmentation (HQC) · Ophthalmology
K240169 · Decided Jul 26, 2024 · 186 days after receipt
Device type: Unit, Phacofragmentation (HQC) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.